Antibiotice Ia (ATB) — Cash Flow Reinvestment Rate
Antibiotice Ia (ATB) has a Cash Flow Reinvestment Rate of 2.63x as of June 2026, reinvesting RON49.25 Million (capex RON49.25 Million ) from operating cash flow of RON18.71 Million. See financial agility of Antibiotice Ia to measure the company's free cash flow as a share of total liabilities.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Antibiotice Ia Cash Flow Reinvestment Rate (2022–2025)
Historical reinvestment intensity for Antibiotice Ia across 4 annual periods. Explore debt repayment capacity of Antibiotice Ia to assess how comfortably operating cash covers total debt obligations.
Annual Cash Flow Reinvestment Rate for Antibiotice Ia (2022–2025)
Year-by-year capital reinvestment analysis for Antibiotice Ia. For the full cash flow conversion analysis, see Antibiotice Ia (ATB) cash flow conversion.
| Year | Reinvestment Rate | Total Reinvested (RON) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 1.97x | RON142.61 Million | RON72.44 Million | RON142.61 Million | ▼ -19.4% |
| 2024 | 2.44x | RON232.32 Million | RON95.15 Million | RON116.16 Million | ▲ +52.5% |
| 2023 | 1.60x | RON196.07 Million | RON122.46 Million | RON98.04 Million | ▲ +132.2% |
| 2022 | 0.69x | RON79.76 Million | RON115.66 Million | RON39.88 Million | — |